Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
bacterial infection
cerebrovascular accident
cerebrovascular accident, mimics
chlorpropamide
coma
diabetes mellitus
drug induced neurologic disorders
genetic neurologic disorders
hemiparesis
hypoglycemia
hypoglycemic agent, oral
hypoglycemic coma
iatrogenic neurologic disorders
insulin
level of consciousness, decreased
mimics
mortality
old age, neurology of
optic neuropathy
optic neuropathy, toxic
seizure
tolazamide
transketolase
visual loss
Wernicke's encephalopathy
Showing articles 1200 to 1250 of 4542 << Previous Next >>

Advanced Brain Imaging Studies Should Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42-2666-2667,2670, Parsons, M.W., 2011

Advanced Brain Imaging Studies Should Not Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42:2668-2669,2670, Lyden, P.D., 2011

Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke A Meta-Analysis of Individual Patient Data
Stroke 42:2515-2520, Zinkstok, S.M.,et al, 2011

Effects of Extending the Time Window of Thrombolysis to 4.5 Hours Observations in the Swedish Stroke Register (Riks-Stroke)
Stroke 42:2492-2497, Asplund, K.,et al, 2011

Progressive Multifocal Leukoencephalopathy in Transplant Recipients
Ann Neurol 70:305-322, Mateen, F.J.,et al, 2011

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011

Clinicopathologic Conference, Susacs Syndrome (retinocochleocerebral vasculopathy)
NEJM 365:549-559, Case 24-2011, 2011

Progressive Multifocal Leukoencephalopathy: Prognosis and treatment
UpToDate, June, Koralnik, I.J.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Clinicopathologic Conference, hemophagocytic lymphohistiocytosis
NEJM 364:1259-1270, Case 10-2011, 2011

Anticoagulation in Patients with Stroke With Infective Edocarditis Is Safe
Stroke 42:1795-1796,1799, Rasmussen, R.V., 2011

Anticoagulation Should Not Be Used in Most Patients With Stroke With Infective Endocarditis
Stroke 42:1797-1798,1799, Sila, C., 2011

Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics
Stroke 42:1771-1774, Tsivgoulis, G.,et al, 2011

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NEJM 364:22, Wechsler, L.R., 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Clinicopathologic Conference, Sjogrens syndrome with dorsal-root ganglionitis
NEJM 364:1856-1865, Case 14-2011, 2011

Multimodal Imaging Does Not Delay Intravenous Thrombolytic Therapy in Acute Stroke
AJNR 32:864-68, Salottolo, K.M.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Use and monitoring of low dose rituximab in myasthenia gravis
JNNP 82:659-663, Blum, S., et al, 2011

Helicopter Transport of Stroke Patients and Its Influence on Thrombolysis Rates
Stroke 42:1295-1300, Reiner-Deitemyer, V.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011

Statin Use Following Intracerebral Hemorrhage
Arch Neurol 68:573-579, Westover, M.B.,et al, 2011

Population-based study of wake-up strokes
Neurol 76:1662-1667, Mackey, J.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

Autoimmune encephalitis
BMJ 342:d1918, Irani, S.R.,et all, 2011

A Case of Hashimoto Encephalopathy Clinical Manifestation, Imaging, Pathology, Treatment, and Prognosis
The Neurologist 17:141-143, Zhao, W.,et al, 2011

Mycophenolate Mofetil May Be Effective in CNS Sarcoidosis But Not in Sarcoid Myopathy
Neurol 76:1168-1172, Androdias,G.,et al, 2011

Increased Risk of Stroke After Discontinuation of Acetlysalicylic Acid: A UK Primary Care Study
Neurol 76:740-746, Rodr�guez,L.A.G.,et al, 2011

Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and Mortality
JAMA 305:373-380, Xian,Y.,et al, 2011

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:512-584, Goldstein,L.B.,et al, 2011

Hemorrhagic Transformation of Childhood Arterial Ischemic Stroke
Stroke 42:941-946, Beslow,L.A.,et al, 2011

Primary Varicella Zoster Infection Associated With Fingolimod Treatment
Neurol 76:1023-1024, Uccelli,A.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Beh�et Disease: Evolution of Clincal Manifestations
Medicine 90:125-132, Ideguchi,H.,et al, 2011

Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Fulminant Encephalopathy With Basal Ganglia Hyperintensities in HIV-Infected Drug Users
Neurol 76:787-794, Newsome,S.D.,et al, 2011

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011

Lingual Hematoma After Thrombolytic Therapy
NEJM 364:e13, Vijayan,S. &Chase,A., 2011

Tumefactive Demyelination, an Uncommon Form of Tacrolimus Neurotoxicity
Neurol 76:672-674, Kim,S.H.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011

Primary Central Nervous System T-Cell Lymphoma of the Brain
Open Neurosurg J 4:62-65, Behbahami, M. & Lyons, M., 2011

Headache in Transplant Patients
www.medlink.com, Aug, Lai, T.H., 2011

Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011



Showing articles 1200 to 1250 of 4542 << Previous Next >>